Vascular endothelial growth factor attenuates status epilepticus-induced behavioral impairments in rats

Epilepsy and Behavior

Volumn 19, Issue 3, 2010, Pages 272-277

  Nicoletti, Jamee N ^a   Lenzer, Janice ^a   Salerni, Elisa A ^a   Shah, Sachin K ^b   Elkady, Ahmed ^b   Khalid, Sidra ^b   Quinteros, Dean ^b   Rotella, Francis ^b   Betancourth, David ^b   Croll, Susan D ^a,b,c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

Anxiety; Cognition; Growth factor; Hippocampus; Learning; Memory; Neuroprotection; Status epilepticus; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN 165;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CELL DENSITY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; EMOTION; EPILEPTIC STATE; HIPPOCAMPUS; HISTOPATHOLOGY; LEARNING; MALE; MAZE TEST; MEMORY; NERVE CELL; NEUROPROTECTION; NONHUMAN; PYRAMIDAL NERVE CELL; RAT;

ADAPTATION, OCULAR; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIORAL SYMPTOMS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; LOCOMOTION; MALE; MAZE LEARNING; PILOCARPINE; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; STATUS EPILEPTICUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78649906687     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.07.011     Document Type: Article

References (34)

1. Storkebaum E., Lambrechts D., Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. BioEssays 2004, 26:943-954.
2. Nicoletti J.N., Shah S.K., McCloskey D.P., et al. Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus. Neuroscience 2008, 151:232-241.
3. Pitkänen A., Nissinen J., Nairismägi J., et al. Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog Brain Res 2002, 135:67-83.
4. Henshell D.C., Simon R.P. Epilepsy and apoptosis pathways. J Cereb Blood Flow Metab 2005, 25:1557-1572.
5. Briellmann R.S., Berkovic S.F., Syngeniotis A., King M.A., Jackson G.D. Seizure-associated hippocampal volume loss: a longitudinal magnetic resonance study of temporal lobe epilepsy. Ann Neurol 2002, 51:641-644.
6. Fuerst D., Shah J., Shah A., Watson C. Hippocampal sclerosis is a progressive disorder: a longitudinal volumetric MRI study. Ann Neurol 2003, 53:413-416.
7. Thom M., Zhou J., Martinian L., Sisodiya S. Quantitative post-mortem study of the hippocampus in chronic epilepsy: seizures do not inevitably cause neuronal loss. Brain 2005, 128(Pt. 6):1344-1357.
8. Goldstein L.H. Neuropsychological investigation of temporal lobe epilepsy. J R Soc Med 1991, 84:460-465.
9. Moore P.M., Baker G.A. The neuropsychological and emotional consequences of living with intractable temporal lobe epilepsy: implications for clinical management. Seizure 2002, 11:224-230.
10. Gröticke I., Hoffmann K., Löscher W. Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice. Exp Neurol 2008, 207:329-349.
11. Müller C.J., Gröticke I., Bankstahl M., Löscher W. Behavioral and cognitive alterations, spontaneous seizures, and neuropathology developing after a pilocarpine-induced status epilepticus in C57BL/6 mice. Exp Neurol 2009, 219:284-297.
12. Sun Q.J., Duan R.S., Wang A.H., et al. Alterations of NR2B and PSD-95 expression in hippocampus of kainic acid-exposed rats with behavioural deficits. Behav Brain Res 2009, 201:292-299.
13. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972, 32:281-294.
14. Rudge J.S., Mather P.E., Pasnikowski E.M., et al. Endogenous BDNF protein is increased in adult rat hippocampus after a kainic acid induced excitotoxic insult but exogenous BDNF is not neuroprotective. Exp Neurol 1998, 149:398-410.
15. Croll S.D., Suri C., Compton D.L., et al. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience 1999, 93:1491-1506.
16. Watson R.E., Wiegand S.J., Clough R.W., Hoffman G.E. Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 1986, 7:155-159.
17. West M.J., Slomianka L., Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991, 231:482-497.
18. McCloskey D.P., Croll S.D., Scharfman H.E. Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures. J Neurosci 2005, 25:8889-8897.
19. Charney D.S., Bremner D. The neurobiology of anxiety disorders. Neurobiology of mental illness 1999, 494-517. Oxford Univ. Press, New York. D.S. Charney, E.J. Nestler, B.S. Bunney (Eds.).
20. Liu X., Muller R.U., Huang L.T., et al. Seizure-induced changes in place cell physiology: relationship to spatial memory. J Neurosci 2003, 23:11505-11515.
21. Brun V.H., Ytterbo K., Morris R.G., Moser M.B., Moser E.I. Retrograde amnesia for spatial memory induced by NMDA receptor-mediated long-term potentiation. J Neurosci 2001, 21:356-362.
22. Leung L.S., Shen B. Hippocampal CA1 kindling but not long-term potentiation disrupts spatial memory performance. Learn Mem 2006, 13:18-26.
23. Scott R.C., Surtees R.A.H., Neville B.G.R. Status epilepticus: pathophysiology, epidemiology, and outcomes. Arch Dis Child 1998, 79:73-77.
24. Chapman A.G. Glutamate and epilepsy. J Nutr 2000, 130:1043-1045.
25. Fujikawa D.G. Prolonged seizures and cellular injury: understanding the connection. Epilepsy Behav 2005, 7:3-11.
26. Morris R.G., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 1986, 319:774-776.
27. Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci 1992, 15:353-375.
28. Miyamoto E. Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus. J Pharmacol Sci 2006, 100:433-442.
29. Shukla K., Kim J., Blundell J., Powell C.M. Learning-induced glutamate receptor phosphorylation resembles that induced by long-term potentiation. J Biol Chem 2007, 282:18100-18107.
30. Szyndler J., Piechal A., Blecharz-Klin K., et al. Effect of kindled seizures on rat behavior in water Morris maze test and amino acid concentrations in brain structures. Pharmacol Rep 2006, 58:75-82.
31. Bruhn T., Christensen T., Diemer N.H. Evidence for increased cellular uptake of glutamate and aspartate in the rat hippocampus during kainic acid seizures: a microdialysis study using the 'indicator diffusion' method. Epilepsy Res 1997, 26:363-371.
32. Nonaka M., Kohmura E., Yamashita T., et al. Increased transcription of glutamate-aspartate transporter (GLAST/GluT-1) mRNA following kainic acid-induced limbic seizure. Brain Res Mol Brain Res 1998, 55:54-60.
33. Ghijsen W.E., da Silva Aresta Belo A.I., Zuiderwijk M., Lopez da Silva F.H. Compensatory change in EAAC1 glutamate transporter in rat hippocampus CA1 region during kindling epileptogenesis. Neurosci Lett 1999, 276:157-160.
34. Croll S.D., McCloskey D.P., Nicoletti J.N., Scharfman H.E. VEGF as a seizure therapeutic: killing two birds with one stone. Growth factors and epilepsy 2005, Nova Sciences, New York. D.K. Binder, H.E. Scharfman (Eds.).